Tarsus Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with various eye diseases. With a commitment to advancing ophthalmic treatments, Tarsus is dedicated to improving the lives of individuals suffering from conditions such as dry eye disease and Meibomian gland dysfunction. Through its cutting-edge research and development, the company aims to provide novel solutions that address the unmet needs of patients worldwide.